NR4A1 and breast carcinoma: The majority of tumor samples were of primary breast cancers (96%), invasive ductal carcinoma histology (89%), moderately to poorly differentiated (73%), stage I or II at initial diagnosis (71%), and hormone receptor status (estrogen receptor (ER)/progesterone receptor (PR)) positive (73%).